Completion of Offering Triggers Conversion of $7.3 Million of Debt to Equity
SAN DIEGO, CA , April 02, 2018 -- Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, today announced the completion of its previously announced public offering of its Series B Convertible Preferred Stock in which it raised aggregate proceeds of $3,621,143. Youngevity received net proceeds of $3,328,761 in the offering.
Each preferred share was priced at $9.50 and is initially convertible at any time, in whole or in part, at the option of the holders, into two shares of common stock of Youngevity International, NASDAQ, YGYI.
Tripoint Global Equities acted as lead managing selling agent and book runner through its BANQ® platform.
The completion of the offering creates a forced conversion of debt Youngevity sold in its 2017 private placement into 1,577,032 shares of common stock at a conversion price of $4.60 and relieves Youngevity of $7.3 million of existing debt.
Proceeds from the sale of the convertible preferred are expected to be used for working capital in the company’s coffee and direct selling divisions.
Dave Briskie, President and CFO of Youngevity, stated, “We structured this offering in a manner that allowed broad participation so it was more than just a capital raise for us. For years we had discussed the possibility of creating an opportunity for our loyal distributors and customers to become shareholders in our company. Utilizing Tripoint’s BANQ platform allowed us to meet this objective as it provided the opportunity for participation at a low minimum investment. Additionally, we realized that by reaching a certain threshold in this raise we had the opportunity to convert $7.3 million of debt into permanent capital, equity, and obviously relieve our balance sheet of that debt. We are extremely pleased that with this closing we have achieved over a $10.5 million improvement to our balance sheet”
“We are pleased to be a part of the Youngevity offering and provide the seamless conduit utilizing our BANQ platform to all to allow the distributors to become shareholders and help contribute the future success of the Company, “stated Mark Elenowitz, CEO TriPoint Global Equities.
About Youngevity International, Inc.
Youngevity International, Inc. (NASDAQ : YGYI), is a leading omni-direct lifestyle company -- offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company's food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions, and includes statements regarding the anticipated use of proceeds. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue our international growth, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance, and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2017 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Investor Relations: Chuck Harbey PCG Advisory Group [email protected] P: 646.863.7997


Anta Sports Expands Global Footprint With Strategic Puma Stake
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



